PHLDA3 and prostate carcinoma: Similarly, the PHLDA3 mRNA and protein levels were increased upon G6PD knockdown and decreased upon G6PD overexpression in the human PTEN null PC3 prostate cancer cells (Fig. 5d, right panel), indicating that PHLDA3 expression is negatively regulated by the PPP.